JP2011252020A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011252020A5 JP2011252020A5 JP2011179129A JP2011179129A JP2011252020A5 JP 2011252020 A5 JP2011252020 A5 JP 2011252020A5 JP 2011179129 A JP2011179129 A JP 2011179129A JP 2011179129 A JP2011179129 A JP 2011179129A JP 2011252020 A5 JP2011252020 A5 JP 2011252020A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- buprenorphine
- withdrawal syndrome
- kit
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims 17
- 206010048010 Withdrawal syndrome Diseases 0.000 claims 15
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 claims 12
- 229960001736 buprenorphine Drugs 0.000 claims 12
- 239000006211 transdermal dosage form Substances 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000002552 dosage form Substances 0.000 claims 5
- 206010013663 drug dependence Diseases 0.000 claims 3
- 208000011117 substance-related disease Diseases 0.000 claims 3
- 239000000499 gel Substances 0.000 claims 2
- 239000006210 lotion Substances 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- 229940127240 opiate Drugs 0.000 claims 2
- 230000036470 plasma concentration Effects 0.000 claims 2
- 231100000572 poisoning Toxicity 0.000 claims 2
- 230000000607 poisoning effect Effects 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- 206010052804 Drug tolerance Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49040703P | 2003-07-25 | 2003-07-25 | |
| US60/490,407 | 2003-07-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521307A Division JP2007500134A (ja) | 2003-07-25 | 2004-07-26 | 依存性退薬症状の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011252020A JP2011252020A (ja) | 2011-12-15 |
| JP2011252020A5 true JP2011252020A5 (enExample) | 2012-11-01 |
Family
ID=34115390
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521307A Pending JP2007500134A (ja) | 2003-07-25 | 2004-07-26 | 依存性退薬症状の治療 |
| JP2011179129A Pending JP2011252020A (ja) | 2003-07-25 | 2011-08-18 | 依存性退薬症状の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521307A Pending JP2007500134A (ja) | 2003-07-25 | 2004-07-26 | 依存性退薬症状の治療 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8637073B2 (enExample) |
| EP (1) | EP1646328B1 (enExample) |
| JP (2) | JP2007500134A (enExample) |
| KR (1) | KR100829492B1 (enExample) |
| CN (1) | CN1829482B (enExample) |
| AT (1) | ATE375149T1 (enExample) |
| AU (1) | AU2004261182B2 (enExample) |
| BR (1) | BRPI0412931A (enExample) |
| CA (1) | CA2530005C (enExample) |
| CY (1) | CY1107262T1 (enExample) |
| DE (1) | DE602004009449T2 (enExample) |
| DK (1) | DK1646328T3 (enExample) |
| EA (1) | EA009921B1 (enExample) |
| ES (1) | ES2295929T3 (enExample) |
| GE (1) | GEP20125454B (enExample) |
| HR (1) | HRP20070476T3 (enExample) |
| IL (1) | IL173346A (enExample) |
| IS (1) | IS2630B (enExample) |
| MA (1) | MA28004A1 (enExample) |
| MX (1) | MXPA06000991A (enExample) |
| NO (1) | NO333189B1 (enExample) |
| NZ (1) | NZ545505A (enExample) |
| PL (1) | PL1646328T3 (enExample) |
| PT (1) | PT1646328E (enExample) |
| SI (1) | SI1646328T1 (enExample) |
| UA (1) | UA81056C2 (enExample) |
| WO (1) | WO2005011579A2 (enExample) |
| ZA (1) | ZA200510069B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| EP1913938A1 (en) * | 2002-12-13 | 2008-04-23 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| MXPA05006334A (es) * | 2002-12-13 | 2005-08-26 | Euro Celtique Sa | Dosis de buprenorfina transdermica para analgesia. |
| DK1646328T3 (da) | 2003-07-25 | 2008-02-04 | Euro Celtique Sa | Behandling af afhængighedsophör |
| CN101316623A (zh) * | 2005-09-30 | 2008-12-03 | Tti优而美株式会社 | 系统输送活性剂的离子电渗方法和装置 |
| US9700552B2 (en) * | 2008-02-28 | 2017-07-11 | Syntropharma Limited | Pharmaceutical compositions for treatment of addiction |
| US8163731B2 (en) * | 2008-08-20 | 2012-04-24 | Rhodes Technologies | Method and dosage regimens for eliminating a chemical substance in blood |
| US9879204B2 (en) | 2010-03-17 | 2018-01-30 | Method Products, Pbc | Liquid cleaning compositions with lower freezing point |
| US11236351B2 (en) | 2010-05-17 | 2022-02-01 | Dow Agrosciences Llc | Production of DHA and other LC PUFAs in plants |
| TW201307553A (zh) | 2011-07-26 | 2013-02-16 | Dow Agrosciences Llc | 在植物中生產二十二碳六烯酸（ｄｈａ）及其他長鏈多元不飽和脂肪酸（ｌｃ－ｐｕｆａ）之技術 |
| EP2844236B1 (en) * | 2012-04-17 | 2018-12-19 | Purdue Pharma LP | Systems and methods for treating an opioid-induced adverse pharmacodynamic response |
| US9849124B2 (en) | 2014-10-17 | 2017-12-26 | Purdue Pharma L.P. | Systems and methods for treating an opioid-induced adverse pharmacodynamic response |
| JP7061568B2 (ja) * | 2016-01-08 | 2022-04-28 | オハイオ・ステイト・イノベーション・ファウンデーション | オピオイド新生児薬物離脱症候群の処置及び予防 |
| CA3068036A1 (en) | 2017-06-30 | 2019-01-03 | Purdue Pharma L.P. | Use to buprenorphine in combination with an opioid to treat pain |
| CN107648234A (zh) * | 2017-08-04 | 2018-02-02 | 中国人民解放军第二军医大学 | 一种治疗吗啡成瘾戒断症状的阿片类药物组合物 |
| CA3066284A1 (en) * | 2018-04-09 | 2019-10-17 | Katana Pharmaceuticals, Inc. | Oxytocin compositions and methods of use |
| US20220288061A1 (en) * | 2019-09-02 | 2022-09-15 | Camurus Ab | Formulations and treatment methods |
| CA3207013A1 (en) * | 2021-02-01 | 2022-08-04 | Xinhua Li | Sequestration compounds for treatment of substance use disorder and uses thereof |
| EP4568672A2 (en) * | 2022-08-12 | 2025-06-18 | Bioventures, Llc | Deuterated buprenorphine as a protective agent for fetal subjects against full-agonist opioid exposure |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4058599A (en) | 1973-02-24 | 1977-11-15 | Bayer Aktiengesellschaft | Ethyleneimine inactivated organisms |
| DE3939376C1 (enExample) * | 1989-11-29 | 1991-05-08 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De | |
| US5075341A (en) | 1989-12-01 | 1991-12-24 | The Mclean Hospital Corporation | Treatment for cocaine abuse |
| EP0432945A1 (en) * | 1989-12-12 | 1991-06-19 | Warner-Lambert Company | A transdermal delivery system for treatment of cocaine and heroin addiction |
| US5272149A (en) * | 1992-05-05 | 1993-12-21 | Stalling Reginald W | Symptom controlled receptor substitution for addiction withdrawl |
| JPH06183956A (ja) * | 1992-12-24 | 1994-07-05 | Teisan Seiyaku Kk | 安定な貼付用の製剤 |
| JP2819236B2 (ja) | 1994-05-06 | 1998-10-30 | 日東電工株式会社 | 経皮吸収製剤 |
| EP0821957A3 (en) * | 1996-08-01 | 1998-04-22 | Eli Lilly And Company | Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse |
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| KR100383252B1 (ko) | 1998-12-17 | 2003-07-16 | 주식회사 삼양사 | 부프레놀핀을함유하는경피투여조성물및이를포함하는패취 |
| AU2002348135A1 (en) | 2001-10-31 | 2003-05-12 | Recovery Pharmaceuticals, Inc. | Methods for the treatment of addiction |
| ES2305457T3 (es) | 2002-03-20 | 2008-11-01 | Euro-Celtique S.A. | Metodo de administracion de buprenorfina para tratar la depresion. |
| MXPA05006334A (es) | 2002-12-13 | 2005-08-26 | Euro Celtique Sa | Dosis de buprenorfina transdermica para analgesia. |
| WO2004103317A2 (en) | 2003-05-15 | 2004-12-02 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for treatment of diarrhea |
| DK1646328T3 (da) | 2003-07-25 | 2008-02-04 | Euro Celtique Sa | Behandling af afhængighedsophör |
-
2004
- 2004-07-26 DK DK04779186T patent/DK1646328T3/da active
- 2004-07-26 NZ NZ545505A patent/NZ545505A/en not_active IP Right Cessation
- 2004-07-26 WO PCT/US2004/024010 patent/WO2005011579A2/en not_active Ceased
- 2004-07-26 EA EA200600200A patent/EA009921B1/ru not_active IP Right Cessation
- 2004-07-26 UA UAA200602136A patent/UA81056C2/uk unknown
- 2004-07-26 CA CA2530005A patent/CA2530005C/en not_active Expired - Fee Related
- 2004-07-26 GE GEAP20049184A patent/GEP20125454B/en unknown
- 2004-07-26 JP JP2006521307A patent/JP2007500134A/ja active Pending
- 2004-07-26 AU AU2004261182A patent/AU2004261182B2/en not_active Ceased
- 2004-07-26 US US10/566,121 patent/US8637073B2/en active Active
- 2004-07-26 KR KR1020067001688A patent/KR100829492B1/ko not_active Expired - Fee Related
- 2004-07-26 AT AT04779186T patent/ATE375149T1/de active
- 2004-07-26 SI SI200430545T patent/SI1646328T1/sl unknown
- 2004-07-26 MX MXPA06000991A patent/MXPA06000991A/es active IP Right Grant
- 2004-07-26 EP EP04779186A patent/EP1646328B1/en not_active Expired - Lifetime
- 2004-07-26 DE DE602004009449T patent/DE602004009449T2/de not_active Expired - Lifetime
- 2004-07-26 CN CN2004800215633A patent/CN1829482B/zh not_active Expired - Fee Related
- 2004-07-26 PL PL04779186T patent/PL1646328T3/pl unknown
- 2004-07-26 HR HR20070476T patent/HRP20070476T3/xx unknown
- 2004-07-26 PT PT04779186T patent/PT1646328E/pt unknown
- 2004-07-26 ES ES04779186T patent/ES2295929T3/es not_active Expired - Lifetime
- 2004-07-26 BR BRPI0412931-8A patent/BRPI0412931A/pt not_active Application Discontinuation
-
2005
- 2005-12-12 ZA ZA200510069A patent/ZA200510069B/en unknown
- 2005-12-19 IS IS8187A patent/IS2630B/is unknown
-
2006
- 2006-01-24 IL IL173346A patent/IL173346A/en not_active IP Right Cessation
- 2006-02-23 MA MA28830A patent/MA28004A1/fr unknown
- 2006-02-24 NO NO20060913A patent/NO333189B1/no not_active IP Right Cessation
-
2008
- 2008-01-08 CY CY20081100020T patent/CY1107262T1/el unknown
-
2011
- 2011-08-18 JP JP2011179129A patent/JP2011252020A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011252020A5 (enExample) | ||
| JP2007500134A5 (enExample) | ||
| JP2013173796A5 (enExample) | ||
| JP2011511071A5 (enExample) | ||
| JP2012193216A5 (enExample) | ||
| JP2008044951A5 (enExample) | ||
| JP2010525050A5 (enExample) | ||
| JP2016517434A5 (enExample) | ||
| CY1107262T1 (el) | Θεραπεια της εξαρτησης στερησης | |
| FI3626270T3 (fi) | Sydän- ja verisuonitautien hoito | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| JP2015522015A5 (enExample) | ||
| CN102648279B (zh) | 用于治疗药物诱发的手足综合征的组合物与方法 | |
| BRPI0510895A (pt) | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t | |
| RU2015127834A (ru) | Способы лечения диабета путем введения антагониста рецептора глюкагона в сочетании с ингибитором поглощения холестерина | |
| JP2013540734A5 (enExample) | ||
| CA2525202A1 (en) | Use of alpha interferon, ribavirin, dsrna and neuraminidase inhibitors to treat avian influenza | |
| JP2009539916A5 (enExample) | ||
| CN104173363B (zh) | 一种腺苷化合物在制备防治应激障碍药物中的用途 | |
| CN104936585B (zh) | 包括苯肾上腺素和扑热息痛的组合药剂 | |
| JP2010523660A5 (enExample) | ||
| AU2019385373A1 (en) | Application of chidamide in combination with R-CHOP, and drug combination | |
| CN104147036B (zh) | 地西他滨和奥沙利铂在制备治疗肾细胞癌组合药物中应用 | |
| JP2011513315A5 (enExample) | ||
| CN103263435B (zh) | 聚维酮碘的制药用途 |